| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 4,204,000 | | Cost of Revenue | 2,428,000 | | | Gross Profit | 1,776,000 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 361,000 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 1,415,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19,000 | | Earnings Before Interest And Taxes | 1,434,000 | | Interest Expense |
-
| | Income Before Tax | 1,434,000 | | Income Tax Expense | 547,000 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 887,000 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 887,000 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $887,000 |
|
0.02% Nasdaq 
0.49%
Income Statement
